Rvc Biofund
In June 2010 the Board of Directors of RVC has approved the Conceptual Framework of RVC Biofund. In early 2011, the fund started its operations. The Biofund was necessitated by a low share of Russian innovative drugs, amounting today to less than 1%. With virtually zero infrastructure to develop biopharma and medical start-ups, foreign services devour 50% to 80% of Russian investment resources. To remedy this, RVC BioFund will be investing capital into service companies of this cluster and biotech start-ups. Additionally, it will be launching an ecosystem to generate and incubate as many biotech projects as possible. The Fund focus covers innovative biopharma companies and service companies providing contract, laboratory, analytical and consulting services to biotechnological, pharmaceutical and medical companies.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
11 to 50
headcount range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Rvc Biofund
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Rvc Biofund
2 distinct titles indexed · top 2 shown.
- 1analyst
- 1chief accountant
Sign up to unlock all 2 contacts at Rvc Biofund
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Rvc Biofund
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.